Lincoln National Corp’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,959	Closed	-$1.33M	–	344
2024 Q1	$1.33M	Sell	13,959 -106	-0.8%	-$8.9K	0.02%	433
2023 Q4	$1.07M	Sell	14,065 -169	-1%	-$11.8K	0.02%	442
2023 Q3	$986K	Sell	14,234 -2,702	-16%	-$217K	0.02%	410
2023 Q2	$1.6M	Sell	16,936 -832	-5%	-$72.3K	0.03%	306
2023 Q1	$1.47M	Sell	17,768 -12,572	-41%	-$988K	0.03%	297
2022 Q4	$2.26M	Buy	30,340 +3,617	+14%	+$279K	0.05%	204
2022 Q3	$2.21M	Buy	26,723 +1,112	+4%	+$107K	0.05%	194
2022 Q2	$2.44M	Buy	25,611 +117	+0.5%	+$12.1K	0.06%	185
2022 Q1	$3M	Sell	25,494 -447	-2%	-$50.1K	0.06%	163
2021 Q4	$3.36M	Sell	25,941 -494	-2%	-$57.6K	0.07%	148
2021 Q3	$2.99M	Buy	26,435 +604	+2%	+$68.9K	0.07%	158
2021 Q2	$2.67M	Buy	25,831 +2,438	+10%	+$230K	0.06%	175
2021 Q1	$1.96M	Sell	23,393 -2,765	-11%	-$234K	0.05%	195
2020 Q4	$2.39M	Buy	26,158 +1,367	+6%	+$113K	0.06%	158
2020 Q3	$1.98M	Buy	24,791 +1,741	+8%	+$136K	0.06%	167
2020 Q2	$1.59M	Buy	23,050 +445	+2%	+$31.6K	0.05%	180
2020 Q1	$1.42M	Buy	22,605 +2,868	+15%	+$207K	0.05%	161
2019 Q4	$1.53M	Buy	19,737 +6,525	+49%	+$510K	0.05%	185
2019 Q3	$969K	Buy	13,212 +453	+4%	+$31.8K	0.04%	230
2019 Q2	$786K	Buy	+12,759	New	+$772K	0.03%	242
2019 Q1	–	Sell	-7,587	Closed	-$387K	–	519
2018 Q4	$387K	Buy	7,587 +2,073	+38%	+$105K	0.02%	303
2018 Q3	$320K	Buy	5,514 +168	+3%	+$8.22K	0.01%	348
2018 Q2	$259K	Buy	5,346 +591	+12%	+$27.6K	0.01%	397
2018 Q1	$221K	Sell	4,755 -3,669	-44%	-$159K	0.01%	428
2017 Q4	$316K	Buy	+8,424	New	+$309K	0.01%	483